Today, leading global communications network Havas hosts its inaugural "GLP101 Day" conference to showcase a holistic view of GLP-1 drugs and explore the significant disruptions brought on by their ...

The biotech said it would use the cash to “further accelerate” a portfolio led by its GLP-1 receptor agonist MET-097, which ...

Supplements promising similar results to Ozempic have taken over social media, but the TGA and health experts have concerns.

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or ...

The South African Health Products Regulatory Authority (Sahpra) has issued a warning to the public to refrain from buying and ...

Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...

For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor ...

A total of 20,146 patients with nephrolithiasis and type 2 diabetes, including those with gout at baseline, initiated an SGLT ...

The oral presentation "Islet-Targeted GLP-1 Receptor Agonist Gene Therapy Reduces Fat and Improves Metabolism in Obese Mice" highlighted new preclinical data on sustained weight maintenance and ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

REMAIN-1 weight maintenance pivotal study enrollment progressing rapidly; mid-point data analysis expected in Q2 2025 ...

"Our progress in the third quarter was highlighted by the compelling topline results from our Phase 1 study of TERN-601, ...